Target Name: ZFTRAF1
NCBI ID: G50626
Review Report on ZFTRAF1 Target / Biomarker Content of Review Report on ZFTRAF1 Target / Biomarker
ZFTRAF1
Other Name(s): zinc finger TRAF-type containing 1 | CHRP | cysteine and histidine rich protein | CYHR1 | Cysteine and histidine rich 1 | cysteine and histidine rich 1 | OTTHUMP00000228763 | Cysteine/histidine-rich 1 | Cysteine and histidine-rich protein 1 (isoform 1) | KIAA0496 | MGC13010 | OTTHUMP00000228765 | Zinc finger TRAF-type-containing protein 1 | Cysteine and histidine rich 1, transcript variant 1 | OTTHUMP00000228770 | OTTHUMP00000228772 | cysteine/histidine-rich 1 | cysteine and histidine-rich protein 1 | OTTHUMP00000228771 | CYHR1 variant 1 | OTTHUMP00000228773 | Cysteine and histidine rich protein

ZFTRAF1: A Potential Drug Target and Biomarker

Zinc finger traf-type containing 1 (ZFTRAF1) is a protein that has been identified as a potential drug target and biomarker in various diseases, including cancer. ZFTRAF1 is a protein that is expressed in most tissues of the body and is involved in various cellular processes, including cell signaling, DNA replication, and apoptosis.

The ZFTRAF1 protein is composed of four zinc fingers and a single N-terminal transmembrane domain. ZFTRAF1 functions as a transcription factor that regulates gene expression by binding to specific DNA sequences. ZFTRAF1 has been shown to play a role in various cellular processes, including cell proliferation, differentiation, and apoptosis.

One of the most significant functions of ZFTRAF1 is its role in cell signaling. ZFTRAF1 has been shown to play a role in regulating cell signaling pathways, including the TGF-β pathway. TGF-β is a well-known signaling pathway that is involved in various cellular processes, including cell growth, differentiation, and cancer. ZFTRAF1 has been shown to regulate the activity of the TGF-β pathway by binding to the TGF-β receptor and preventing the binding of the TGF-β signaling protein SMAD.

In addition to its role in cell signaling, ZFTRAF1 has also been shown to play a role in DNA replication and apoptosis. ZFTRAF1 has been shown to play a role in regulating the DNA replication process by binding to the DNA replication protein DNAPK. DNAPK is a protein that is involved in regulating DNA replication and has been shown to play a role in various diseases, including cancer. ZFTRAF1 has also been shown to play a role in regulating apoptosis, a process that is involved in the programmed cell death that occurs in many diseases, including cancer.

The potential drug target for ZFTRAF1 is its role in cell signaling, as well as its involvement in various cellular processes that are associated with the development and progression of cancer. ZFTRAF1 has been shown to play a role in the regulation of cell proliferation, differentiation, and apoptosis, which are all processes that are critical for the development and progression of cancer.

In conclusion, ZFTRAF1 is a protein that has been identified as a potential drug target and biomarker in various diseases, including cancer. ZFTRAF1's functions in cell signaling, DNA replication, and apoptosis make it an attractive target for drug development. Further research is needed to fully understand the role of ZFTRAF1 in various diseases and to develop effective treatments.

Protein Name: Zinc Finger TRAF-type Containing 1

The "ZFTRAF1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZFTRAF1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZFX | ZFX-AS1 | ZFY | ZFYVE1 | ZFYVE16 | ZFYVE19 | ZFYVE21 | ZFYVE26 | ZFYVE27 | ZFYVE28 | ZFYVE9 | ZFYVE9P1 | ZG16 | ZG16B | ZGLP1 | ZGPAT | ZGRF1 | ZHX1 | ZHX1-C8orf76 | ZHX2 | ZHX3 | ZIC1 | ZIC2 | ZIC3 | ZIC4 | ZIC5 | ZIK1 | ZIM2 | ZIM3 | Zinc finger protein GLI | ZKSCAN1 | ZKSCAN2 | ZKSCAN3 | ZKSCAN4 | ZKSCAN5 | ZKSCAN7 | ZKSCAN8 | ZKSCAN8P1 | ZMAT1 | ZMAT2 | ZMAT3 | ZMAT4 | ZMAT5 | ZMIZ1 | ZMIZ1-AS1 | ZMIZ2 | ZMPSTE24 | ZMYM1 | ZMYM2 | ZMYM3 | ZMYM4 | ZMYM4-AS1 | ZMYM5 | ZMYM6 | ZMYND10 | ZMYND11 | ZMYND12 | ZMYND15 | ZMYND19 | ZMYND8 | ZNF10 | ZNF100 | ZNF101 | ZNF106 | ZNF107 | ZNF112 | ZNF114 | ZNF117 | ZNF12 | ZNF121 | ZNF124 | ZNF131 | ZNF132 | ZNF133 | ZNF134 | ZNF135 | ZNF136 | ZNF137P | ZNF138 | ZNF14 | ZNF140 | ZNF141 | ZNF142 | ZNF143 | ZNF146 | ZNF148 | ZNF154 | ZNF155 | ZNF157 | ZNF16 | ZNF160 | ZNF165 | ZNF169 | ZNF17 | ZNF174 | ZNF175 | ZNF177 | ZNF18 | ZNF180 | ZNF181